Genomics of Smoldering Multiple Myeloma: Time for Clinical Translation of Findings?

Lionetti, Marta; Da Vià, Matteo C; Albano, Francesco; Neri, Antonino; Bolli, Niccolò; Musto, Pellegrino

Lionetti, Marta; Da Vià, Matteo C; Albano, Francesco; Neri, Antonino; Bolli, Niccolò; Musto, Pellegrino.

Afiliación

Lionetti M; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Da Vià MC; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
Albano F; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Neri A; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
Bolli N; Department of Emergency and Organ Transplantation, "Aldo Moro" University School of Medicine, 70124 Bari, Italy.
Musto P; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Cancers (Basel) ; 13(13)2021 Jul 01.

Article en En | MEDLINE | ID: mdl-34282760

Palabras clave

asymptomatic stages; genomic alterations; multiple myeloma; tumor evolution

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google